iColonâ„¢ iFOB Test Kit
Dive into our easy guide on catching colorectal cancer early and keeping you and your family safe.
Early Detection of Cancer Can Save Lives
Annually, cancer accounts for 10 million deaths and 19.3 million new cases worldwide (1). Cancer's progression from early to late stages underscores the critical importance of early detection. Identifying cancer when tumors are small and localized can significantly improve survival rates, with surgery and possibly radiotherapy or chemotherapy preventing recurrence.
However, a significant number of cancer patients are diagnosed at a late stage— one-third in the case of breast cancer and half in the case of colorectal cancer (CRC)—so they have missed the best treatment window (2). Early detection improves the prognosis through successful treatment opportunities (3).
If there are screening tests to find cancer earlier, patients diagnosed in late stages may likely still survive, reducing family emotional and financial burdens. Unfortunately, only a few cancers have early screening tests to help reduce risks currently.
Colorectal Cancer (CRC) Is One of the Few Cancers That Can Be Detected Early
Colorectal cancer (CRC) is one of the few cancer types that have screening methods for early detection. Cancer screening tests do not diagnose cancer but provide information on the possibility of the presence of cancer cells or early signs of cancer. CRC screening tests, with their advantages and disadvantages, are recommended to the general population at average risk to identify the high CRC-risk population at an early stage (4). See our resources page to see what methods are available for CRC screening.
​
Although CRC screening can prevent 90% of deaths and there are different screening tests available, there is still more than one-third of the eligible population in the US who have not been screened (5). The different reasons for noncompliance include unawareness, ignorance, discomfort with the tests, lack of insurance, urban poverty, or rural access limitation.
Colorectal Cancer Screening Guideline from American Cancer Society
01.
According to the American Cancer Society, colorectal cancer screening should be done for people aged between 45 to 74 (6).
02.
The guideline has changed the younger age from 50 to 45 due to an increasing younger population diagnosed with CRC. The US Prevention Services Task Force has similar recommendations for CRC screening (7).
DiaCarta iColon™ iFOB (FIT) Test Kit
FDA 510(k) Approved
What is the iColon™ iFOB Test Kit?
Unlike traditional FIT at-home tests that require sending stool samples to labs with a two-week wait, the DiaCarta iColon™ iFOB Test Kit offers rapid, at-home results within 4-7 minutes. It screens for colon polyps, diverticulitis, colitis, and is an effective tool for colorectal cancer screening.
​
How the iColon™ iFOB Test Kit Works
The iColon™ iFOB Test Kit utilizes a lateral flow immunochemical assay to detect hidden blood in stool samples with 99% accuracy. Users collect a small stool sample, mix it with a provided solution, and apply three drops to the test cassette. The sample migrates to test lines T and C. Blood hemoglobin binds to an antibody, indicating presence by coloring the T-line. There should always be a colored C-line because without it the test would be invalid. This kit is also available for healthcare providers for on-site patient screening.
Results in 4 to 7 Minutes
99% Accuracy
No Diet Restrictions
No Need to Ship Back to Lab
